Haoxi Health Technology announces 1-for-128 reverse share split

Haoxi Health Technology (HAO) announced that it will effect a reverse share split of its outstanding Class A ordinary shares and Class B ordinary shares at a ratio of 1-for-128. Class A ordinary shares will begin trading on a reverse share split-adjusted basis at the opening of The Nasdaq Capital Market on May 21. Following the reverse share split, the Class A ordinary shares and Class B ordinary shares will have a new par value of 32c per share and the Class A ordinary shares will continue to trade on Nasdaq under the symbol “HAO” with the new CUSIP number, G4290F126. The reverse share split will reduce the number of issued and outstanding Class A ordinary shares from 235,504,007 to approximately 1,839,876, and the number of issued and outstanding Class B ordinary shares from 690,800 to approximately 5,397, subject to any adjustments resulting from the treatment of the fractional shares.